SB 1094 Prescribes requirements for the interchange of anti-epileptic drugs
Sponsor: Loudon
LR Number: 4643S.03C Fiscal Note: 4643-03
Committee: Seniors, Families and Public Health
Last Action: 5/16/2008 - S Informal Calendar S Bills for Perfection--SB 1094-Loudon, with SCS Journal Page:
Title: SCS SB 1094 Calendar Position:
Effective Date: August 28, 2008

Full Bill Text | All Actions | Available Summaries | Senate Home Page | List of 2008 Senate Bills

Current Bill Summary

SCS/SB 1094 - This act provides that a pharmacy, when filling a prescription that has been prescribed for the treatment of epilepsy that denotes that the drug is from a specific manufacturer, be it generic or name brand, shall not interchange the drug for any other from another manufacturer other than the one specified in the prescription, unless the patient is notified of the interchange upon the delivery of the prescription. If such drug is interchanged, the pharmacy that fills such prescription shall notify the prescribing physician within forty-eight hours of the delivery of the prescription. The requirement under this act shall not apply to prescriptions dispensed for inpatients of a hospital, nursing home, assisted living facility, or inpatients of a mental health or residential facility.

This act is identical to SB 634 (2007).